Do you want to read an article? Please log in or register.
Covid-19 and Myeloma: what are the implications for now and in the future?
Multiple Myeloma (MM)
Related content
RECOMMENDED
COVID-19
COVID-19 and its implications for thrombosis and anticoagulation
★ 3
Recommended by
PD Dr Sara De Dosso, Faculty Member
doi: 10.1182/blood.2020006000.
Multiple Myeloma (MM)COVID-19
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
Blood
Chari A, Samur MK, Martinez-Lopez J, Cook G, Biran N, Yong K, Hungria V, Engelhardt M, Gay F, García Feria A, Oliva S, Oostvogels R, Gozzetti A, Rosenbaum C, Kumar S, Stadtmauer EA, Einsele H, Beksac M, Weisel K, Anderson KC, Mateos MV, Moreau P, San-Miguel J, Munshi NC, Avet-Loiseau H
doi: 10.1182/blood.2020008150
Further Publications
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
Eur J Cancer.
de Joode K, Dumoulin DW, Tol J, Westgeest HM, Beerepoot LV, van den Berkmortel FWPJ, Mutsaers PGNJ, van Diemen NGJ, Visser OJ, Oomen-de Hoop E, Bloemendal HJ, van Laarhoven HWM, Hendriks LEL, Haanen JBAG, de Vries EGE, Dingemans AC, van der Veldt AAM, DOCC Investigators.
doi: 10.1016/j.ejca.2020.09.027.
COVID-19
Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg
Oncol Res Treat.
Weisel KC, Morgner-Miehlke A, Petersen C, Fiedler W, Block A, Schafhausen P, Knobloch JK, Bokemeyer C
doi: 10.1159/000508272.
Breast Cancer
Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortium
Breast Cancer Res Treat.
Dietz JR, Moran MS, Isakoff SJ, Kurtzman SH, Willey SC, Burstein HJ, Bleicher RJ, Lyons JA, Sarantou T, Baron PL, Stevens RE, Boolbol SK, Anderson BO, Shulman LN, Gradishar WJ, Monticciolo DL, Plecha DM, Nelson H, Yao KA
doi: 10.1007/s10549-020-05644-z.
Multiple Myeloma (MM)COVID-19
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
Lancet Haematol
Ludwig H, Sonneveld P, Facon T, San-Miguel J, Avet-Loiseau H, Mohty M, Mateos MV, Moreau P, Cavo M, Pawlyn C, Zweegman S, Engelhardt M, Driessen C, Cook G, Dimopoulos MA, Gay F, Einsele H, Delforge M, Caers J, Weisel K, Jackson G, Garderet L, van de Donk N, Leleu X, Goldschmidt H, Beksac M, Nijhof I, Schreder M, Abildgaard N, Hajek R, Zojer N, Kastritis E, Broijl A, Schjesvold F, Boccadoro M, Terpos E
doi: 10.1016/S2352-3026(21)00278-7
COVID-19
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lancet Oncol.
Lee LYW, Cazier JB, Starkey T, Briggs SEW, Arnold R, Bisht V, Booth S, Campton NA, Cheng VWT, Collins G, Curley HM, Earwaker P, Fittall MW, Gennatas S, Goel A, Hartley S, Hughes DJ, Kerr D, Lee AJX, Lee RJ, Lee SM, Mckenzie H, Middleton CP, Murugaesu N, Newsom-Davis T, Olsson-Brown AC, Palles C, Powles T, Protheroe EA, Purshouse K, Sharma-Oates A, Sivakumar S, Smith AJ, Topping O, Turnbull CD, Várnai C, Briggs ADM, Middleton G, Kerr R, UK Coronavirus Cancer Monitoring Project Team.
doi: 10.1016/S1470-2045(20)30442-3.
SPECIAL REPORT
Multiple Myeloma (MM)Further PublicationsCOVID-19
Treating MM-Patients During the COVID-19 Pandemic: An Interview with Prof. Maria-Victoria Mateos
COVID-19
Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement
CA Cancer J Clin.
Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J
doi: 10.3322/caac.21635.